MiNK Therapeutics Inc
INKT
Get informed when a big investor buys or sells
+ FollowMarket Cap$60.78M
Close$
$-0.09
100.7% downside
Current Fair Value
100.7% downsideOvervalued by 100.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $60.78 Million |
|---|---|
| Enterprise Value | $-9,464,896,832.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.93 |
| Beta | 0.47 |
| Outstanding Shares | 4,798,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | -174.60% |
| Return on Invested Capital | 0.20% |
Valuation & Multiples
| P/E Ratio | -4.69 |
|---|---|
| PEG | 533.82 |
| Price to Sales | - |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1525.65 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.77
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-0.87
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.95%▼ 0.62% |
|---|---|
| Total Invested | $1.32M▼ 21.92% |
| Investors Holding | 22▼ 2.00% |
ESG Score
No data